SEC. 2. AUTHORITY OF NATIONAL DRUG CONTROL POLICY 
WITH RESPECT TO THE WORLD ANTI-DOPING 
AGENCY. 
Section 701 of the Office of National Drug Control 
Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is 
amended— 
(1) in subsection (a)— 
(A) by amending paragraph (1) to read as 
follows: 
‘‘(1) 
UNITED
STATES
OLYMPIC
AND 
PARALYMPIC COMMITTEE.—The term ‘United States 
Olympic and Paralympic Committee’ means the or-
ganization established by chapter 2205 of title 36, 
United States Code.’’; 
(B) in paragraph (3), by striking ‘‘(36 
U.S.C. 
22501(b)(1))’’ 
and 
inserting 
‘‘(36 
U.S.C. 220501(b)(1))’’; 
(C) by redesignating paragraphs (1) and 
(3) as paragraphs (4) and (1), respectively, and 
moving the paragraphs so as to appear in nu-
meric order; and 
(D) by inserting after paragraph (2) the 
following: 
‘‘(3) 
INDEPENDENT
ATHLETE.—The 
term 
‘independent 
athlete’ 
means 
an 
Olympic 
or 
VerDate Sep 11 2014 
01:06 Aug 30, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H9220.IH
H9220
ssavage on LAPJG3WLY3PROD with BILLS
Paralympic athlete who does not serve, in any capac-
ity— 
‘‘(A) on the International Olympic Com-
mittee; 
‘‘(B) on the International Paralympic 
Committee; 
‘‘(C) at an international sports federation 
recognized by the International Olympic Com-
mittee or the International Paralympic Com-
mittee; 
‘‘(D) on the United States Olympic and 
Paralympic Committee; or 
‘‘(E) at the World Anti-Doping Agency.’’; 
(2) in subsection (b)— 
(A) by striking ‘‘United States Olympic 
Committee’’ each place it appears and inserting 
‘‘United States Olympic and Paralympic Com-
mittee’’; 
(B) in paragraph (5), by striking the pe-
riod at the end and inserting ‘‘; and’’; and 
(C) by adding at the end the following: 
‘‘(6) carry out responsibilities with respect to 
the World Anti-Doping Agency, as described in sub-
section (d).’’; and 
(3) by adding at the end the following: 
VerDate Sep 11 2014 
01:06 Aug 30, 2024
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H9220.IH
H9220
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(d) AUTHORITY WITH RESPECT TO THE WORLD 
ANTI-DOPING AGENCY.— 
‘‘(1) IN
GENERAL.—The Office of National 
Drug Control Policy, in consultation with the United 
States Anti-Doping Agency, the United States Olym-
pic and Paralympic Committee, and the Team USA 
Athletes’ Commission, shall— 
‘‘(A) use all available tools to ensure 
that— 
‘‘(i) the World Anti-Doping Agency 
has a credible and independent governance 
model that provides for fair representation 
of the United States; 
‘‘(ii) the World Anti-Doping Agency 
fully implements all governance reforms, 
including a proper conflict-of-interest pol-
icy for all members of the Executive Com-
mittee, the Foundation Board, and all rel-
evant expert advisory groups, standing 
committees, permanent special committees, 
and working groups of the World Anti- 
Doping Agency; and 
‘‘(iii) independent athletes from the 
United States and other democratic coun-
tries, or representatives of such athletes, 
VerDate Sep 11 2014 
01:06 Aug 30, 2024
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H9220.IH
H9220
ssavage on LAPJG3WLY3PROD with BILLS
have decision-making roles on the Execu-
tive Committee and the Foundation Board, 
and in all relevant expert advisory groups, 
standing committees, permanent special 
committees, and working groups, of the 
World Anti-Doping Agency; 
‘‘(B) demonstrate leadership within the 
global community; 
‘‘(C) have strict standards that work to-
ward countering doping in every form, including 
by countering systemic fraud through doping 
involving— 
‘‘(i) governmental law enforcement, 
intelligence, or anti-doping institutions; 
‘‘(ii) sporting organizations; or 
‘‘(iii) athlete support personnel; and 
‘‘(D) work collaboratively with democratic 
countries. 
‘‘(2) DETERMINATION.— 
‘‘(A) IN
GENERAL.—Not later than 90 
days after the date of the enactment of this 
subsection, the Office of National Drug Control 
Policy, in consultation with the United States 
Anti-Doping Agency, the United States Olympic 
and Paralympic Committee, and the Team USA 
VerDate Sep 11 2014 
01:06 Aug 30, 2024
Jkt 049200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H9220.IH
H9220
ssavage on LAPJG3WLY3PROD with BILLS
Athletes’ Commission, shall make a determina-
tion as to whether the World Anti-Doping 
Agency— 
‘‘(i) has a credible and independent 
governance model that provides for fair 
representation of the United States; 
‘‘(ii) fully implements all governance 
reforms, including a proper conflict-of-in-
terest 
policy 
described 
in 
paragraph 
(1)(A)(ii); and 
‘‘(iii) allows independent athletes from 
the United States and other democratic 
countries, or representatives of such ath-
letes, to have decision-making roles on the 
Executive Committee and the Foundation 
Board, and in all relevant expert advisory 
groups, standing committees, permanent 
special committees, and working groups, of 
the World Anti-Doping Agency. 
‘‘(B) ACCOUNTABILITY.—In the case of a 
determination under subparagraph (A) that the 
World Anti-Doping Agency does not have such 
a governance model, has not fully implemented 
such governance reforms, or has not allowed de-
cision-making roles described in clause (iii) of 
VerDate Sep 11 2014 
01:06 Aug 30, 2024
Jkt 049200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H9220.IH
H9220
ssavage on LAPJG3WLY3PROD with BILLS
that subparagraph, the Office of National Drug 
Control Policy, in consultation with the United 
States Anti-Doping Agency, the United States 
Olympic and Paralympic Committee, and the 
Team USA Athletes’ Commission, shall— 
‘‘(i) use all available tools to ensure 
that the United States has fair representa-
tion in the World Anti-Doping Agency, in-
cluding— 
‘‘(I) on the Executive Committee; 
‘‘(II) on the Foundation Board; 
and 
‘‘(III) in all relevant expert advi-
sory groups, standing committees, 
permanent special committees, and 
working groups of the World Anti- 
Doping Agency; and 
‘‘(ii) not later than 180 days after the 
date on which the determination under 
subparagraph (A) is made, issue a report 
that describes the barriers to participation 
and fair representation of the United 
States on the Executive Committee, the 
Foundation Board, and all relevant expert 
advisory groups, standing committees, per-
VerDate Sep 11 2014 
01:06 Aug 30, 2024
Jkt 049200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H9220.IH
H9220
ssavage on LAPJG3WLY3PROD with BILLS